About this trial
People with chest pain are often tested for a heart attack using a blood test called high-sensitivity cardiac troponin (hs-cTn). Traditionally, this blood test is repeated 3 hours after the first sample. Newer guidelines recommend repeating the test after 1 hour instead, which may allow patients to receive a diagnosis and leave the hospital sooner.
The purpose of the DanRUSH trial is to compare these two strategies: repeating the blood test after 1 hour versus after 3 hours in adults with suspected acute coronary syndrome. The study will evaluate whether the 1-hour strategy is as safe as the 3-hour strategy while reducing the length of hospital stay.
DanRUSH is a nationwide, pragmatic, cluster-randomized trial conducted in emergency- and cardiology departments across Denmark. The results will help determine the best timing for blood testing in patients with suspected heart attack and improve future care for these patients.
Eligibility criteria
Qualifiers
Adults (≥18 years) presenting with suspected acute coronary syndrome (ACS) with a clinical indication for high-sensitivity cardiac troponin testing
Disqualifiers
Age <18 years.
ST-segment elevation myocardial infarction (STEMI) identified on the presenting electrocardiogram and requiring immediate reperfusion therapy.
Trial design
Treatments tested in this trial
- 0/3-hour high-sensitivity cardiac troponin algorithm
- 0/1-hour high-sensitivity cardiac troponin algorithm
Treatment groups
Sponsors and collaborators
Herlev and Gentofte Hospital
Lead sponsor
Bispeberg and Frederiksberg Hospital
Collaborator
Hvidovre and Amager Hospital
Collaborator
North Zealand (Hillerød) Hospital
Collaborator
Nykøbing Falster Sygehus
Collaborator
Gødstrup Hospital
Collaborator
Regionshospitalet Viborg, Skive
Collaborator
Odense Universitetshospital
Collaborator
Esbjerg sygehus
Collaborator
Aalborg University Hospital
Collaborator